GHRS
GH Research PLC
NASDAQ · Healthcare · Biotechnology · IE
$28.23
+1.11%Leverage
- Debt / equity
- 0.00x
- Net debt / equity
- -0.96x
- Debt / assets
- 0.00x
- Debt / EBITDA
- -0.01x
- Net debt / EBITDA
- 5.59x
Liquidity & coverage
- Current ratio
- 28.70x
- Quick ratio
- 28.70x
- Cash ratio
- 28.22x
- Interest coverage
- -355.41x
- EBITDA / interest
- -307.02x
- Working capital
- $356.0M
Cash & dividend
- FCF / debt
- -145.91x
- Cash flow / debt
- -145.52x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026